deltatrials
Completed PHASE3 INTERVENTIONAL 1-arm NCT03352323

An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea

Evaluation of the Reduction in Erythema by Oxymetazoline Hydrochloride Topical Cream, 1% in Adults With Moderate to Severe Facial Erythema Associated With Rosacea

Sponsor: Padagis LLC

Conditions Erythema Rosacea
Interventions Oxymetazoline
Updated 12 times since 2017 Last updated: Nov 5, 2021 Started: Oct 18, 2017 Primary completion: Dec 6, 2017 Completion: Mar 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Erythema and Rosacea and is currently completed. Padagis LLC leads this study, which shows 12 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshotRecruiting~Jan 2018 – ~May 2018 · 4 months · monthly snapshotRecruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotCompleted~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshotCompleted~Feb 2019 – ~Jan 2021 · 23 months · monthly snapshotCompleted~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshotCompleted~Feb 2021 – ~Dec 2021 · 10 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  5. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE3

▶ Show 7 earlier versions

  1. Feb 2021 — Dec 2021 [monthly]

    Completed PHASE3

  2. Jan 2021 — Feb 2021 [monthly]

    Completed PHASE3

  3. Feb 2019 — Jan 2021 [monthly]

    Completed PHASE3

  4. Jun 2018 — Feb 2019 [monthly]

    Completed PHASE3

  5. May 2018 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  6. Jan 2018 — May 2018 [monthly]

    Recruiting PHASE3

  7. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE3

    First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Padagis LLC
Data source: Padagis LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations